Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 11 - 14 crawled time : 00:20 save search
Akero Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-12 (Crawled : 00:20) - ir.akerotx.com
AKRO | $20.23 -3.67% -3.81% 580K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
financial results results
Vaccinex, Inc. to Present at the Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
Published: 2021-11-09 (Crawled : 00:20) - ir.vaccinex.com
VCNX | $4.9631 -2.76% 3.5K
|
Health Technology
|
| O: -0.51%
H: 5.08%
C: 4.06%
disease alzheimer clinical trials vaccine trials trial alzheimer’s alzheimer's disease alzheimer's
Liberty All-Star Equity Fund October 2021 Monthly Update
Published: 2021-11-13 (Crawled : 00:20) - prnewswire.com
PYPL 4 | $64.84 0.64% 0.63% 7.8M
|
Technology Services
| Email alert
Add to watchlist
NOW | $746.29 0.72% -4.85% 1.6M
|
Technology Services
| Email alert
Add to watchlist
AMZN S | $176.57 -1.65% -3.18% 32M
|
Retail Trade
| Email alert
Add to watchlist
SNEJF | News | $81.888 2.78% 42K
|
Consumer Durables
| Email alert
Add to watchlist
AIG | $74.97 0.05% 0.0% 2.7M
|
Finance
| Email alert
Add to watchlist
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Meta Platforms, Inc. f/k/a Facebook, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - FB
Published: 2021-11-13 (Crawled : 00:20) - prnewswire.com
FB S | $196.64 0.51%
|
Technology Services
| Email alert
Add to watchlist
deadline platform
DEADLINE: Snap Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - SNAP
Published: 2021-11-13 (Crawled : 00:20) - prnewswire.com
AAPL | $168.99 1.25% 1.24% 48M
|
Electronic Technology
| Email alert
Add to watchlist
SNAP | News S | $11.08 -2.72% -4.25% 31M
|
Technology Services
| Email alert
Add to watchlist
deadline
ooma-nov-2021-grandstream-offers-table
Published: 2021-11-13 (Crawled : 00:20) - ooma.com
OOMA 4 | $6.71 -1.76% 0.0% 130K
|
Technology Services
| Email alert
Add to watchlist
What Every stanozolol 10mg uk Need To Know About Facebook
Published: 2021-11-13 (Crawled : 00:20) - oncocyte.com
HOLX | $76.71 -0.62% -0.63% 910K
|
Health Technology
| Email alert
Add to watchlist
OCX | News | $2.3 -6.31% -6.74% 41K
|
Health Technology
| Email alert
Add to watchlist
Aadi Bioscience Presents Two Abstracts on FYARRO (nab-Sirolimus) at the Annual Meeting of the Connective Tissue Oncology Society (CTOS)
Published: 2021-11-13 (Crawled : 00:20) - globenewswire.com
AADI | $1.79 -2.72% -2.79% 110K
|
Manufacturing
| Email alert
Add to watchlist
NextCure and Collaborators Provide Clinical and Research Updates on NC318 and NC410 Candidates at Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-11-13 (Crawled : 00:20) - globenewswire.com
NXTC | $1.43 -6.54% -6.99% 180K
|
Health Technology
| Email alert
Add to watchlist
immunotherapy therapy cancer research
Video Release — Virginia-Class Attack Submarine New Jersey (SSN 796) Christened at Newport News Shipbuilding
Published: 2021-11-13 (Crawled : 00:20) - globenewswire.com
HII | $275.84 0.5% -0.65% 490K
|
Electronic Technology
| Email alert
Add to watchlist
marine
Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Combination with Pembrolizumab in Advanced Cancers at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2021-11-13 (Crawled : 00:20) - globenewswire.com
IOVA 4 | $11.69 -1.43% -1.45% 2.7M
|
Health Technology
| Email alert
Add to watchlist
immunotherapy therapy cancer iot
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.